Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Q04206 (TF65_HUMAN) Homo sapiens (Human)

Transcription factor p65 UniProtKBInterProSTRINGInteractive Modelling

551 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 1 identical sequence: Gorilla gorilla gorilla: G3SHV6

Available Structures

88 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
I-KAPPA-B-ALPHA/NF-KAPPA-B COMPLEX Heteromer
P19838; P25963;
20-314
Assess
Crystal Structure of NFkB, IRF7, IRF3 bound to the interferon-b enhancer Heteromer
P19838; Q14653; Q92985;
20-291
Assess
Crystal structure of a higher-order complex of p50:RelA bound to the HIV-1 LTR Heteromer
P19838;
20-291
Assess
NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transacti… Heteromer
P32776;
521-551
Assess
NMR structure of the complex between the KIX domain of CBP and the transactivation domain 1 of p65 Heteromer
P45481;
521-551
Assess
Structure of importin a3 bound to the p50- and p65-NLSs Heteromer
O00629; P19838;
299-311
Assess
solution structures of BRD4 second bromodomain with NF-kB-K310ac peptide Heteromer
O60885;
304-316
Assess
14-3-3 sigma with RelA/p65 binding site pS45 in complex with DP005 Heteromer
P31947;
42-50
CL;0V4;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-182 Heteromer
P31947;
43-51
UVZ;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-185 Heteromer
P31947;
43-51
UT8;CL;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-184 Heteromer
P31947;
43-51
UVK;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-180 Heteromer
P31947;
43-51
TVB;CA;CL;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-183 Heteromer
P31947;
43-51
UVE;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-188 Heteromer
P31947;
43-51
UST;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-179 Heteromer
P31947;
43-51
TQW;GOL;CA;CL;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-046 Heteromer
P31947;
43-51
CL;V0T;CA;GOL;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 Heteromer
P31947;
43-51
GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-192 Heteromer
P31947;
43-51
V2N;V2K;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-187 Heteromer
P31947;
43-51
TW8;CA;CL;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-186 Heteromer
P31947;
43-51
USW;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-181 Heteromer
P31947;
43-51
UVQ;CL;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521 Heteromer
P31947;
43-51
L3Y;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound LvD1009 Heteromer
P31947;
43-51
TJ8;MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-124 Heteromer
P31947;
43-51
UGN;CA;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-070 Heteromer
P31947;
43-51
GOL;CA;UHZ;CL;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-153 Heteromer
P31947;
43-51
U1B;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-083 Heteromer
P31947;
43-51
V48;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-133 Heteromer
P31947;
43-51
UGE;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-127 Heteromer
P31947;
43-51
UVT;CL;MG;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-122 Heteromer
P31947;
43-51
UWQ;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-069 Heteromer
P31947;
43-51
CL;TZH;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-120 Heteromer
P31947;
43-51
UXN;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-111 Heteromer
P31947;
43-51
UON;UOT;PEG;CL;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-130 Heteromer
P31947;
43-51
UVN;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-132 Heteromer
P31947;
43-51
GOL;CL;UG8;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-142 Heteromer
P31947;
43-51
TWQ;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-116 Heteromer
P31947;
43-51
CL;CA;GOL;PEG;V1K;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-134 Heteromer
P31947;
43-51
UVH;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-131 Heteromer
P31947;
43-51
UVB;MG;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-096 Heteromer
P31947;
43-51
V3Z;CL;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-126 Heteromer
P31947;
43-51
UHN;CA;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-154 Heteromer
P31947;
43-51
TZW;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-123 Heteromer
P31947;
43-51
P7E;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-135 Heteromer
P31947;
43-51
UHQ;GOL;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-097 Heteromer
P31947;
43-51
V42;CA;CL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-121 Heteromer
P31947;
43-51
UWK;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-157 Heteromer
P31947;
43-51
V2E;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-125 Heteromer
P31947;
43-51
UWH;CA;CL;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-117 Heteromer
P31947;
43-51
V0W;CL;MG;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-080 Heteromer
P31947;
43-51
V4N;CL;CA;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-176 Heteromer
P31947;
43-51
CL;V4H;CA;PEG;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-164 Heteromer
P31947;
43-51
CL;V3B;PEG;MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-044 Heteromer
P31947;
43-51
CL;TZK;GOL;CA;MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-158 Heteromer
P31947;
43-51
CL;V2Q;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-033 Heteromer
P31947;
43-51
CL;P6Z;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-037 Heteromer
P31947;
43-51
CL;P6H;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-168 Heteromer
P31947;
43-51
CL;V3T;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-041 Heteromer
P31947;
43-51
CL;V1Q;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-175 Heteromer
P31947;
43-51
CL;TWE;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-173 Heteromer
P31947;
43-51
CL;V3W;CA;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-011 Heteromer
P31947;
43-51
CL;P5N;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-165 Heteromer
P31947;
43-51
CL;V3K;GOL;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-025 Heteromer
P31947;
43-51
CL;L3S;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-028 Heteromer
P31947;
43-51
CL;P5Q;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-042 Heteromer
P31947;
43-51
CL;V1E;CA;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-085 Heteromer
P31947;
43-51
CL;V4B;CA;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-161 Heteromer
P31947;
43-51
CL;V32;MG;PEG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-159 Heteromer
P31947;
43-51
CL;V2T;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-166 Heteromer
P31947;
43-51
CL;V3N;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-027 Heteromer
P31947;
43-51
CL;L3V;CA;MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-043 Heteromer
P31947;
44-51
V0Q;MG;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-128 Heteromer
P31947;
43-50
UGQ;CL;CA;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-129 Heteromer
P31947;
43-50
P7T;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-118 Heteromer
P31947;
44-51
CL;GOL;UHW;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-167 Heteromer
P31947;
43-50
CL;V3Q;MG;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-178 Heteromer
P31947;
43-50
CL;V4K;CA;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-045 Heteromer
P31947;
44-51
CL;V1H;MG;
Assess
Structure of importin a2 bound to p65-NLS Heteromer
P52293;
299-306
Assess
14-3-3 sigma with p65 (RelA) binding site pS45 and covalently bound PC2046 Heteromer
P31947;
43-49
UQN;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-119 Heteromer
P31947;
43-49
CL;CA;UHT;
Assess
Crystal Structure of Brd4 Bromodomain 1 in Complex with Acetylated Rel Peptide Heteromer
O60885;
308-314
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-160 Heteromer
P31947;
43-49
CL;V2W;MG;GOL;
Assess
14-3-3 sigma with RelA/p65 binding site pS45 and covalently bound TCF521-110 Heteromer
P31947;
43-48
S9E;PEG;
Assess
Human SETD6 in complex with RelA Lys310 peptide Heteromer
Q8TBK2;
307-312
10×EDO;SAM;
Assess
Structure of importin a2 bound to the p50- and p65-NLSs Heteromer
P19838; P52293;
299-304
Assess
Brd4 Bromodomain 2 in Complex with Acetylated Rel Peptide Heteromer
O60885;
308-312
DTT;
Assess
14-3-3 sigma with RelA/p65 binding site pS281 Heteromer
P31947;
280-282
Assess
Human SETD6 in complex with RelA Lys310 Heteromer
Q8TBK2;
310-310
SAM; 11×EDO;
Assess

4 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2o61.1.Cmonomer0.8320-291
96.45
Assess
1nfi.1.Amonomer0.7720-313
99.67
Assess
1ooa.1.Bmonomer0.7718-291
44.60
Assess
2lww.1.Bmonomer0.52427-491
81.54
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22o61.1.Cmonomer0.837-278
94.68
Assess
Isoform 21ooa.1.Bmonomer0.776-278
44.76
Assess
Isoform 21nfi.1.Amonomer0.767-300
98.00
Assess
Isoform 22lww.1.Bmonomer0.52414-478
81.54
Assess
Isoform 32o61.1.Cmonomer0.8020-281
96.32
Assess
Isoform 31nfi.1.Amonomer0.7420-303
99.66
Assess
Isoform 31ooa.1.Bmonomer0.7318-281
45.85
Assess
Isoform 32lww.1.Bmonomer0.51417-481
81.54
Assess
Isoform 42o61.1.Cmonomer0.7920-288
95.70
Assess
Isoform 41ooa.1.Bmonomer0.7518-288
47.18
Assess
Isoform 41nfi.1.Amonomer0.7520-310
98.99
Assess
Isoform 42lww.1.Bmonomer0.52424-488
81.54
Assess